Holen Sie sich die Stockscreener-App
11.10
3.23%
-0.37
Finanzdaten der Enanta Pharmaceuticals Inc-Aktie (ENTA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
16.32%
14.36
|
17.16 | 18.61 | 15.12 | 18.31 |
| Research and Development |
13.80%
22.13
|
19.44 | - | 23.81 | 27.21 |
| Costs And Expenses |
8.91%
31.59
|
29.01 | 29.87 | 33.51 | 37.21 |
| Depreciation and Amortization |
1.99%
1.185
|
1.209 | 1.23 | 1.284 | 1.21 |
| Operating Income/Loss |
45.43%
-17.24
|
-11.85 | -11.25 | -18.39 | -18.89 |
| Nonoperating Income/Loss |
80.93%
-2.229
|
-1.232 | -0.661 | -0.282 | 0.667 |
| Income/Loss From Continuing Operations Before Tax |
48.77%
-19.46
|
-13.08 | -11.91 | -18.67 | -18.23 |
| Income Tax Expense/Benefit |
414.29%
0.036
|
0.007 | 0.024 | 0.032 | 0.029 |
| Net Income/Loss |
48.96%
-19.50
|
-13.09 | -11.94 | -18.70 | -18.25 |
| Basic Average Shares |
0.17%
29.09
|
29.04 | 28.75 | - | 21.38 |
| Diluted Average Shares |
0.17%
29.09
|
29.04 | 28.75 | - | 21.38 |
| Basic Earnings Per Share |
48.89%
-0.67
|
-0.45 | -0.42 | - | -0.85 |
| Diluted Earnings Per Share |
48.89%
-0.67
|
-0.45 | -0.42 | - | -0.85 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):